Form 4: Cooper Companies Director Plans Stock Purchase
Insider Transaction Report
Lawrence Erik Kurzius, a Director at Cooper Companies, Inc., reported a planned acquisition of 2,000 shares of common stock at $82.50 per share under a Rule 10b5-1 plan.
Summary
- Lawrence Erik Kurzius, a Director of The Cooper Companies, Inc. (COO), reported a planned acquisition of common stock.
- The transaction involves the purchase of 2,000 shares of common stock.
- The purchase price per share is $82.50.
- Following this transaction, Kurzius will beneficially own 7,777 shares of common stock directly.
- The transaction is scheduled for December 17, 2025, and is being made pursuant to a Rule 10b5-1 pre-arranged trading plan.
- A Power of Attorney, executed on November 3, 2025, authorizes designated individuals to file Section 16 reports on behalf of Mr. Kurzius.
Sentiment
Score: 7
Explanation: A director's planned purchase of company stock, especially under a 10b5-1 plan, generally indicates confidence in the company's future and is a positive signal, though the impact of a single transaction is limited.
Positives
- A Director's planned purchase of company stock signals confidence in the company's future prospects.
- The transaction is part of a Rule 10b5-1 plan, indicating a pre-meditated investment decision.
Future Outlook
The filing indicates a planned future transaction by a director, suggesting a positive outlook on the company's stock performance from an insider's perspective, as the purchase is scheduled for December 17, 2025.
Industry Context
Insider purchases, especially by directors, are often viewed by the market as a sign of confidence in the company's future performance, potentially indicating that the insider believes the stock is undervalued or expects positive developments. This specific transaction is a routine disclosure of a pre-planned purchase.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Lawrence Erik Kurzius granted a Power of Attorney to several individuals (Daniel G. McBride, Greta Kolcon, Mindy Gonzales, Michelle Cloutier, and Lauren Hernandez) to execute and file Forms 3, 4, and 5 on his behalf, ensuring compliance with Section 16(a) of the Securities Exchange Act of 1934. | 11/03/2025 | Streamlines the process for insider trading compliance filings for the director, ensuring timely and accurate reporting of beneficial ownership changes. |
Stakeholder Impact
- Shareholders may view the director's planned stock purchase as a positive indicator of management's confidence in the company's future performance and value.
Next Steps
- The planned acquisition of 2,000 shares of common stock by Director Lawrence Erik Kurzius is scheduled to occur on December 17, 2025.
Key Dates
| Date | Description |
|---|---|
| 11/03/2025 | Execution date of the Power of Attorney by Lawrence Erik Kurzius. |
| 12/17/2025 | Transaction date for the acquisition of 2,000 shares of Cooper Companies common stock by Director Lawrence Erik Kurzius. |
Recommendation
holdWhile a director's planned stock purchase is a positive signal of insider confidence, a single transaction of this size ($165,000) by one director, even under a 10b5-1 plan, is not typically sufficient to warrant a 'buy' recommendation on its own. It reinforces a 'hold' position for existing investors and suggests potential stability or modest upside, but lacks the broader strategic or financial impact for a stronger recommendation.
Keywords
Cooper Companies, COO, Insider Trading, Form 4, Stock Purchase, Director, Equity Acquisition, Rule 10b5-1, Lawrence Erik Kurzius
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.